share_log

4: Statement of changes in beneficial ownership of securities-Officer Philibert Robert

SEC ·  Sep 11 05:24

Summary by Futu AI

On September 6, 2024, Robert Philibert, the Chief Medical Officer of Cardio Diagnostics Holdings, Inc. [CDIO], completed the purchase of a total of 34,075 shares of common stock in two separate transactions. The first transaction involved the acquisition of 26,615 shares at a price of $0.287 per share, while the second transaction saw the purchase of 7,460 shares at $0.2848 per share. Following these transactions, Philibert's total indirect beneficial ownership in the company amounts to 1,683,867 shares. Both acquisitions were made on the open market.
On September 6, 2024, Robert Philibert, the Chief Medical Officer of Cardio Diagnostics Holdings, Inc. [CDIO], completed the purchase of a total of 34,075 shares of common stock in two separate transactions. The first transaction involved the acquisition of 26,615 shares at a price of $0.287 per share, while the second transaction saw the purchase of 7,460 shares at $0.2848 per share. Following these transactions, Philibert's total indirect beneficial ownership in the company amounts to 1,683,867 shares. Both acquisitions were made on the open market.

The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.